ECSS
PCRX icon

Eurizon Capital SGR SpA’s Pacira BioSciences PCRX Stock Holding History

Eurizon Capital SGR SpA’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.2K Hold
1,961
– – ﹤0.01% 1039
2026
Q1 		$45.9K Hold
1,961
– – ﹤0.01% 1032
2025
Q4 		$51.1K Buy
+1,961
New +$46.6K ﹤0.01% 904

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Eurizon Capital SGR SpA's PCRX Position: Q2 2026 in Review

Eurizon Capital SGR SpA held its Pacira BioSciences (PCRX) position steady in Q2 2026 at 1,961 shares worth $49.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1039.

Eurizon Capital SGR SpA first reported a position in PCRX in Q4 2025 and has held it in 3 quarters since. The position peaked at $51.1K in Q4 2025. 253 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

  • Eurizon Capital SGR SpA held 1,961 shares of Pacira BioSciences worth $49.2K as of Q2 2026.
  • Eurizon Capital SGR SpA left its Pacira BioSciences share count unchanged in Q2 2026.
  • Pacira BioSciences made up ﹤0.01% of Eurizon Capital SGR SpA's portfolio in Q2 2026, its #1039 holding.
  • Eurizon Capital SGR SpA first reported a position in Pacira BioSciences in Q4 2025 and has held it in 3 quarters since.
  • Eurizon Capital SGR SpA's Pacira BioSciences position peaked at $51.1K in Q4 2025.
  • 253 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Eurizon Capital SGR SpA's 13F filing for Q2 2026, filed 29 Jul 2026.